E2F1-induced apoptosis: turning killers into therapeutics
- 1 April 2006
- journal article
- review article
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 12 (4), 177-185
- https://doi.org/10.1016/j.molmed.2006.02.002
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- Mutually Exclusive Subsets of BH3-Only Proteins Are Activated by the p53 and c-Jun N-Terminal Kinase/c-Jun Signaling Pathways during Cortical Neuron Apoptosis Induced by ArseniteMolecular and Cellular Biology, 2005
- Drosophila E2F1 Has Context-Specific Pro- and Antiapoptotic Properties during DevelopmentDevelopmental Cell, 2005
- Gene expression profiling of E2F-1-induced apoptosisGene, 2005
- Inhibition of cell proliferation and induction of apoptosis by novel tetravalent peptides inhibiting DNA binding of E2FOncogene, 2003
- Sustained Activation of the JNK Cascade and Rapamycin-Induced Apoptosis Are Suppressed by p53/p21Cip1Molecular Cell, 2003
- Direct coupling of the cell cycle and cell death machinery by E2FNature, 2002
- E2F1 pathways to apoptosisFEBS Letters, 2002
- Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1Oncogene, 2001
- E2F1 Mediates Death of B-amyloid-treated Cortical Neurons in a Manner Independent of p53 and Dependent on Bax and Caspase 3Journal of Biological Chemistry, 2000
- Regulation and Deregulation of E2F1 in Postmitotic Neurons Differentiated from Embryonal Carcinoma P19 CellsExperimental Cell Research, 1999